Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma

Front. Endocrinol., 17 February 2021

https://doi.org/10.3389/fendo.2020.615883